Nicholas Fidelman, Md

This study is testing if combining an immunotherapy drug (pembrolizumab) with a targeted radiation treatment or a procedure to treat liver tumors works better for people with advanced neuroendocrine tumors. The goal is to see if this two-part approach helps the immune system figh…